Robert Zeiser, MD, discusses results of the REACH3 trial in chronic graft-versus-host disease.
Robert Zeiser, MD,
Advertisement
Articles by Robert Zeiser, MD,
Advertisement
Latest Updated Articles
Dr. Zeiser on Results of the REACH3 Trial in Chronic GVHDPublished: December 8th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
Nuvisertib Yields Strong Safety, Promising Efficacy in R/R Myelofibrosis
5